Our objective was to characterize 46 unique, erythromycin-sensitive, and clindamycin-resistant Streptococcus agalactiae strains from S. Korea that displayed a novel phenotype in double-disk diffusion assay. We used polymerase chain reaction to determine presence of erythromycin and clindamycin resistance genes, disc diffusion assays to determine resistance phenotype, and microbroth dilution to determine minimal inhibitory concentration. We detected a novel phenotype in the double-disk diffusion assay for inducible resistance among 46 S. agalactiae strains that were both erythromycin sensitive and clindamycin resistant. Thirty-two strains with the novel phenotype tested positive for erm(B) by DNA-DNA hybridization; sequencing of the erm(B) gene revealed mutations in the ribosomal binding site region in the erm(B) open reading frame, which is consistent with a lack of erythromycin resistance phenotype. Although identified from patients at multiple hospitals, genotyping suggested that the strains are closely related. The new phenotype shows increased sensitivity to clindamycin in the presence of erythromycin.
Introduction

S
treptococcus agalactiae (S. agalactiae) is a common cause of severe infections in neonates, and causes bacteremia and endocarditis in immunocompromised populations. 5 S. agalactiae remains sensitive to treatment with penicillin; erythromycin or clindamycin is the recommended alternative for patients who are b-lactam intolerant. 4 Resistance to erythromycin and clindamycin has increased during the last decade and is mainly attributed to the erythromycin-conferring methylase genes (erm). The erm genes code for ribosomal methylase and confer cross resistance to clindamycin either through constitutive or inducible resistance mechanisms. 1 Thus, resistance to erythromycin and clindamycin often occurs together. Resistance to erythromycin alone can be conferred by the efflux gene mef, and resistance to clindamycin alone can be conferred by the lnu(B) gene that expresses a specific nucleotidyl transferase. 5 As part of a study of antibiotic resistance determinants in S. agalactiae collected in South Korea in 2006-2007, we identified 46 strains that displayed high resistance to clindamycin, yet were sensitive to erythromycin. We performed the double-disk diffusion testing for inducible resistance and observed a novel phenotype characterized by a channel of sensitivity to clindamycin in the presence of erythromycin. The characteristics of this novel phenotype with increased sensitivity to clindamycin in the presence of erythromycin are reported here.
Materials and Methods
Study populations and S. agalactiae isolation
The study collection included 197 colonizing isolates collected from 140 asymptomatic pregnant women (35-37 weeks of gestation) and 233 clinical isolates collected from 231 patients with S. agalactiae infection. One unique isolate per individual was selected for further study (n ¼ 371 7 Written informed consent permitting use of collected specimens and medical records for research purposes was obtained from each patient. Mucus or discharge was collected from patients with infection, and rectal swabs and urine from pregnant women. All isolates were cultured by using a selective medium (Todd-Hewitt broth supplemented with gentamicin [8 mg/ml] and nalidixic acid [15 mg/ ml], or with colistin [10 mg/ml] and nalidixic acid [15 mg/ ml]) to inhibit growth of bacteria other than S. agalactiae. The identity of S. agalactiae strains was confirmed by catalase test followed by a latex agglutination assay (Streptex; Murex Biotech Ltd.). Antibiotic susceptibility for S. agalactiae was tested by two methods: (1) minimal inhibitory concentration (MIC) was determined by broth dilution assays; (2) disc diffusion was used to study inducible resistance to clindamycin in the presence of erythromycin and to identify the novel keyhole phenotype. Strains with MIC 0.25 mg/ml were designated as erythromycin/clindamycin susceptible, whereas MIC 1 mg/ml were designated as erythromycin/ clindamycin resistant. Follow-up disc diffusion testing used commercial antibiotic discs (Oxoid) and Mueller-Hinton with 5% (v/v) sheep blood with erythromycin and clindamycin discs and were interpreted using published Clinical and Laboratory Standards Institute standards. If an isolate was either erythromycin-resistant/clindamycin-susceptible or erythromycin-susceptible/clindamycin-resistant, we performed a disk induction test by placing clindamycin (2 mg) and erythromycin (15 mg) disks 12 mm apart following CLSI recommendations. 2 The plates were examined after incubation at 358C, 5% CO 2 for 20-24 hours; an isolate with a clindamycin disk diffusion zone blunted on the side closest to erythromycin (D test) was considered to be inducible. Strains demonstrating the new phenotype with the clear channel of inhibition between the clindamycin and erythromycin discs were re-tested with different lots of antibiotic discs and media to rule out nonspecific effects. Serotype was determined using the S. agalactiae kit (Essum Ò ).
Detection of resistance genes
Purified S. agalactiae genomic DNA was arrayed on Vivid Gene Array slides (Pall), as previously described. 9 Polymerase chain reaction (PCR) amplification of antibiotic resistance genes was performed using S. agalactiae overnight cultures, 50 pmol of each primer, and 45 ml of Accuprime super mix II (Invitrogen). Primers to detect erm(B), lnu(B), erm(A), and mef(A) were described previously and used to prepare labeled probes. 7 The presence of antibiotic resistance genes was determined using high-throughput DNA-DNA hybridization as previously described, 2 and PCR was performed when hybridization results were inconclusive.
The lnu(B) gene was identified using DNA-DNA hybridization with a probe targeting a 944 bp region of the lnu(B) gene, and hybridization conditions would have detected signal in the absence of a perfect probe-DNA match. For samples that were lnu(B) negative by DNA-DNA hybridization, PCR amplifications were attempted using both colony PCR and purified genomic DNA as template in replicates. If neither of the PCR gave expected size products, the strains were designated as lnu(B) negative.
A 639 bp fragment of ermB gene was amplified using 5 0 -GAA AAG GTA CTC AAC CAA ATA-3 0 and 5 0 -AGT AAC GGT ACT TAA ATT GTT TAC-3 0 (reverse). Primers designed to PCR amplify the entire erm(B) gene in the novel phenotype strains were not successful; hence, a 1,000 bp region encompassing the erm and adjacent genetic region in S. agalactiae was amplified using primers GTATTGTCCGAGAGTGATTGG TC and AACTTACCCGCCATACCACAG from previously published literature on erm-positive S. agalactiae transposon Tn3872. 8 PCR conditions used included denaturation at 948C for 2 minutes, followed by 30 cycles at 948C for 30 seconds of denaturation, 558C for 1 minute, and extension at 728C for 2 minutes. PCR products were purified and sequenced at from 5 0 and 3 0 ends at the DNA Sequencing core, University of Michigan. in a keyhole phenotype. The 46 strains with the novel phenotype were isolated from 28 patients with disease caused by S. agalactiae and 18 pregnant patients undergoing screening for S. agalactiae. The keyhole phenotype strains were isolated from urine (n ¼ 25), rectal swabs (n ¼ 7), vaginal swabs (n ¼ 4), cervical swabs (n ¼ 3), pus (n ¼ 2), wound (n ¼ 1), and 4 from other sites. In seven individuals the keyhole phenotype colonized multiple sites (only one strain per individual was counted toward the 46 strains exhibiting the novel phenotype). Forty-three of these strains (95%) were serotype III; the three remaining strains were serotype Ib and Ia. To determine the relatedness of the strains with the phenotype, we sequenced the S. agalactiae adpH gene to identify polymorphisms. The variable adpH gene has a high number of mutations that are used to differentiate between strains using multi-locus sequence typing. We did not find any sequence differences in the adpH genes from the 46 S. agalactiae strains exhibiting the novel phenotype, suggesting that the strains are closely related genetically.
Results
To identify the cause of clindamycin and erythromycin resistance, we screened for the presence of several genes. The lnu(B) gene is associated with clindamycin resistance, and 42/46 of the erythromycin-susceptible, clindamycin-resistant strains with the keyhole phenotype had lnu(B) by PCR (Table 1) . One isolate was lnu(B) positive by hybridization but tested lnu(B) negative by PCR (data not shown). The three other strains with the keyhole phenotype were lnu(B) negative (Table 1) . Erythromycin and clindamycin resistanceconferring genes erm(A) and mef(A) were not found in any of the strains exhibiting the novel phenotype.
Thirty-two strains displaying the keyhole phenotype were erm(B) positive by DNA-DNA hybridization and PCR (Table 1 ), yet remained phenotypically erythromycin sensitive. PCR amplification of the erm(B) gene revealed a point mutation in the leader sequence (AGGAGT to ATTAGA) and three point mutations in the coding region of the erm(B) gene; at 222 bp (C to T), 224 bp (T to C), and 299 bp (A to G), respectively. These mutations were absent in 30 erythromycin and clindamycin-resistant strains that did not show the keyhole phenotype (data not shown). We were unable to amplify a region of 57 bp from the 3 0 coding region of erm(B) as well as the region immediately downstream of the erm(B) gene in the strains exhibiting the novel phenotype.
MIC values for clindamycin resistance were >8 mg/ml for all strains with the keyhole phenotype (data not shown). We selected five strains to determine the effect of erythromycin on MIC of clindamycin; all exhibited the keyhole phenotype and were erm(B) and lnu(B) positive. However, when the strains were inoculated with erythromycin and clindamycin, the results were mixed; three out of the five strains tested had decreased MIC values for clindamycin when inoculated with low concentrations of erythromycin; the clindamycin MIC values for two other strains remained unchanged (data not shown).
Discussion
We characterized 46 S. agalactiae with a unique keyhole phenotype that is best described as inducible clindamycin sensitivity. The 46 clindamycin-resistant and erythromycinsensitive strains with the phenotype were identified from both clinical and colonizing isolates in South Korea between 2006 and 2007 and did not cluster by hospital. However, genotyping suggested that the strains were closely related. All strains were more susceptible to clindamycin in the presence of erythromycin in the double-disk diffusion assay than suggested from MICs or from a single-disc diffusion assay. Almost all (94%) strains carried the lnuB gene, which codes for clindamycin resistance, and 70% carried a nonfunctional ermB, which is consistent with erythromycinsusceptible phenotype of these strains. The mechanistic basis of the channel of zone inhibition between the erythromycin and the clindamycin disks in strains exhibiting the keyhole phenotype in S. agalactiae strains is not known. Since the novel phenotype was observed in both lnu(B)-positive and lnu(B)-negative strains as well as erm(B)-positive and erm(B)-negative strains, we postulate that the mechanism underlying the novel phenotype is either independent of the erm(B) and lnu(B) genes or is associated with erm and lnu variants that were not detected by probes used for DNA-DNA hybridization or primers used for PCR methods in this study.
Sequence analysis of the erm(B) region in keyhole phenotype strains that were positive for erm(B) revealed point mutations in both the Shine Dalgarno ribosome binding sequences and erm(B) coding regions. Mutations in the Shine and Dalgarno sites are associated with reduced translation and may be responsible for the erythromycin sensitivity of these erm(B)-containing strains. Two point mutations within the erm(B) coding region were also detected in all strains exhibiting the novel phenotype that were positive for erm(B). One mutation codes for an amino acid substitution from Asp174Thr on the erm(B) coding region; Asp174 has been implicated to be important in the binding of the substrate, S-adenosine methionine to erm(B) in Clostridium 3 ; however, their functional significance in strains with the keyhole phenotype is not known. The second mutation, a deletion in the 3 0 end of the erm(B) coding region, would also serve to explain the erythromycin sensitivity of these strains with the In the laboratory, constitutively resistant mutants can be selected at high frequencies from inducible resistant strains in the presence of clindamycin; in a clinical setting, this implies that there is a risk for selecting clindamycin-resistant strains if infections are treated with clindamycin. 6 We do not know the implications of the keyhole phenotype in vivo, but it is possible that these strains would respond to erythromycin therapy.
